Clinical Trials Directory

Trials / Unknown

UnknownNCT01383915

Clinical Risk State for Bipolar Disorder in Adolescents

Characterizing the Clinical Risk State for Bipolar Disorder in Adolescents

Status
Unknown
Phase
Study type
Observational
Enrollment
402 (estimated)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Accepted

Summary

Aim: The purpose of the study is to characterize the at-risk phases preceding a first episode of bipolar disorder and of schizophrenia, and to identify clinical and biological predictors of the disease development. Hypothesis a: Over 6-24 months, 25% of at-risk youth will develop the full manifestations of Bipolar Disorder (BPD) or schizophrenia. Hypothesis b: The symptoms utilized for characterizing the at-risk phase of BPD will differentiate between individuals developing BPD and schizophrenia.

Detailed description

Prospective, naturalistic, cohort study aiming to characterizing the bipolar and psychotic prodrome thoroughly with a variety of clinical and biological measures.

Conditions

Timeline

Start date
2009-09-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2011-06-28
Last updated
2023-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01383915. Inclusion in this directory is not an endorsement.